Torpedo Therapeutics GTM brain

Torpedo Therapeutics is developing precision, closed-loop deep brain stimulation devices for neurological care and research.

category

Adaptive deep brain stimulation

market profile

  • text: DBS is used for Parkinson's disease, essential tremor, dystonia and drug-resistant epilepsy; off-target stimulation can cause side effects.
  • text: Adaptive neurostimulation is a competitive field with established device makers and emerging research platforms.

personas

  • title: Movement disorders neurologist and DBS programmer
    pains:
    • Repeated parameter adjustments require clinic visits and burden patients.
    • Needs to balance symptom control with stimulation-related side effects.
  • title: Functional neurosurgeon and DBS program director
    pains:
    • Existing electrodes can stimulate neighboring brain regions.
    • Needs evidence of surgical safety, long-term performance and compatibility before adopting a new implant.
  • title: Academic neural engineering research lead
    pains:
    • Needs precise recording and stimulation to investigate adaptive treatment.
    • Must validate neural signals and algorithms in clinically relevant settings.

icp

  • text: Academic medical centers with neurosurgery and movement disorder programs performing DBS are potential clinical research partners.
  • text: Neuromodulation research groups developing adaptive neural sensing and stimulation are potential collaborators; commercial customer qualification remains unverified.

message pillars

  • text: Pursue more precise stimulation using miniaturized electrodes.
  • text: Combine sensing and stimulation to support feedback-driven therapy.
  • text: Analyze neural data to inform stimulation adjustments.

objections

  • objection: Is this particular device clinically proven and approved?
    response: Request device-specific trial results and regulatory status. Existing approval of DBS as a therapy does not establish approval of this device.
  • objection: Will the new implant fit our workflow and reduce programming burden?
    response: Discuss surgical workflow, device compatibility and clinical evidence with the team; benefits remain to be validated for this device.

competitors

  • name: Medtronic
    why: Established DBS manufacturer with adaptive stimulation capabilities.
  • name: Boston Scientific
    why: Established DBS system manufacturer competing for neuromodulation programs.
  • name: Newronika
    why: Develops the adaptive AlphaDBS platform.

influencers

  • name: Ingrid van Welie
    url: https://www.linkedin.com/posts/ingrid-van-welie-28095423_thank-you-for-the-spotlight-paul-activity-7291053396210405376-eN9N
    why: Founder and CEO featured in a post about the company's microelectrode work.

keywords

  • adaptive deep brain stimulation
  • closed loop DBS
  • precision neuromodulation electrodes
  • DBS neural sensing
  • DBS programming side effects
  • movement disorder neurostimulation

voice

  • Technical and explanatory
  • Clinically motivated
  • Research oriented

signals

  • text: A DBS center launches an adaptive stimulation study or expands its movement disorders research program.
  • text: A neurosurgical research team is seeking high-resolution neural recording and stimulation capabilities.

pricing

model: unknown

motion

unknown

channels

  • LinkedIn
  • website contact

confidence

low

Founders

  • name: Ingrid van Welie
    title: Founder
    role: Founder
    bio: Ingrid van Welie, PhD, is the Founder and CEO of Torpedo Therapeutics. Ingrid is a neuroscientist and biophysicist and is focused on developing and commercializing new technologies for sensing and modulating the electrical properties of neurons in the brain.

Back to YC companies